This brand name is authorized in Japan
The drug RADICUT contains one active pharmaceutical ingredient (API):
|
1
Edaravone
UNII S798V6YJRP - EDARAVONE
|
|
Edaravone is a member of the substituted 2-pyrazolin-5-one class. It is used for the treatment of amyotrophic lateral sclerosis (ALS). The mechanism by which edaravone exerts its therapeutic effect in patients with ALS is unknown. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N07XX14 | N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1190032S1021, 1190401A1023, 1190401G1026 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
